Javascript must be enabled to continue!
TU‐B‐201‐01: An Overview of TG‐180
View through CrossRef
Radiotherapy is in the era of image guided radiation therapy (IGRT) in which imaging procedures are routinely performed for patient positioning, and target localization. The additional imaging dose delivered may increase risk to the patient and therefore needs to be managed. This lecture provides an overview of the AAPM TG‐180 which is charged with: providing an overview on imaging dose including megavoltage electronic portal imaging (MV EPI), kilovoltage digital radiography (kV DR), Tomotherapy MV‐CT, megavoltage cone‐beam CT (MV‐CBCT) and kilovoltage cone‐beam CT (kV‐CBCT) as well as providing general guidelines for commissioning and managing imaging dose calculations. The dose to radiotherapy (RT) patients resulting from different image guidance procedures is reviewed and recommendations for managing the imaging dose are provided. Different techniques for reducing the image guidance dose are summarized. A recommended threshold beyond which imaging dose should be considered in the treatment planning process is discussed. This lecture also discusses kilovoltage imaging dose determination by calculation and estimation, and inclusion in treatment planning as well as accounting for MV imaging dose and the future of MV imaging.
Learning Objectives:
Learn the different image guidance modalities, typical organ doses resulting from different image procedures, and techniques to reduce the imaging dose;
Understand the imaging dose threshold and rationale for accounting for the imaging dose;
Learn how to account for kV imaging dose
Learn how to account for MV imaging dose and understand the future of MV imaging
Title: TU‐B‐201‐01: An Overview of TG‐180
Description:
Radiotherapy is in the era of image guided radiation therapy (IGRT) in which imaging procedures are routinely performed for patient positioning, and target localization.
The additional imaging dose delivered may increase risk to the patient and therefore needs to be managed.
This lecture provides an overview of the AAPM TG‐180 which is charged with: providing an overview on imaging dose including megavoltage electronic portal imaging (MV EPI), kilovoltage digital radiography (kV DR), Tomotherapy MV‐CT, megavoltage cone‐beam CT (MV‐CBCT) and kilovoltage cone‐beam CT (kV‐CBCT) as well as providing general guidelines for commissioning and managing imaging dose calculations.
The dose to radiotherapy (RT) patients resulting from different image guidance procedures is reviewed and recommendations for managing the imaging dose are provided.
Different techniques for reducing the image guidance dose are summarized.
A recommended threshold beyond which imaging dose should be considered in the treatment planning process is discussed.
This lecture also discusses kilovoltage imaging dose determination by calculation and estimation, and inclusion in treatment planning as well as accounting for MV imaging dose and the future of MV imaging.
Learning Objectives:
Learn the different image guidance modalities, typical organ doses resulting from different image procedures, and techniques to reduce the imaging dose;
Understand the imaging dose threshold and rationale for accounting for the imaging dose;
Learn how to account for kV imaging dose
Learn how to account for MV imaging dose and understand the future of MV imaging.
Related Results
Abstract 4342: 2B3-201, glutathione pegylated liposomal methylprednisolone, prevents chemotherapy-induced neuropathic pain.
Abstract 4342: 2B3-201, glutathione pegylated liposomal methylprednisolone, prevents chemotherapy-induced neuropathic pain.
Abstract
Chemotherapy-induced peripheral neuropathy is a dose-limiting debilitating symptom that can affect many patients treated with anticancer treatments. The res...
Cleft Lip and Palate Repairs in Togo, “Sourire de l’Espoir” Humanitarian Missions’ Experience: A Retrospective Study of 201 Consecutive Cases
Cleft Lip and Palate Repairs in Togo, “Sourire de l’Espoir” Humanitarian Missions’ Experience: A Retrospective Study of 201 Consecutive Cases
Objective: To describe “Sourire de l’Espoir” humanitarian missions on cleft lip and palate (CLP) repair and how it shaped the future of CLP repair in Togo.
_Design_: Retrospective...
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Abstract
Introduction
Microwave ablation (MWA) has emerged as a minimally invasive treatment for patients with inoperable non-small cell lung cancer (NSCLC). However, whether it i...
Antimicrobial resistance pattern of Escherichia coli isolated from imported frozen shrimp in Saudi Arabia
Antimicrobial resistance pattern of Escherichia coli isolated from imported frozen shrimp in Saudi Arabia
Contamination of seafood products with multi-drug-resistant (MDR) bacteria is considered to be a potential source for the spread of MDR bacteria in communities. However, little is ...
Abstract 1345: NAV-201, an orally bioavailable small molecule NK cell activator enhancing antibody-mediated cancer therapies
Abstract 1345: NAV-201, an orally bioavailable small molecule NK cell activator enhancing antibody-mediated cancer therapies
Abstract
Tumors employ a number of mechanisms to suppress a patient’s immune anti-tumor responses. Recently, we uncovered an immunosuppression mechanism that tumors ...
99m
Tc-N-NOET Myocardial Uptake Reflects Myocardial Blood Flow and Not Viability in Dogs With Reperfused Acute Myocardial Infarction
99m
Tc-N-NOET Myocardial Uptake Reflects Myocardial Blood Flow and Not Viability in Dogs With Reperfused Acute Myocardial Infarction
Background
—
N
-Ethoxy-
N
-ethyl-dithiocarbamato-nitrido-
99m
Tc (
99m
T...
A GH Secretagogue Receptor Agonist (LUM-201) Elicits Greater GH Responses than Standard GH Secretagogues in Subjects of a Pediatric GH Deficiency Trial
A GH Secretagogue Receptor Agonist (LUM-201) Elicits Greater GH Responses than Standard GH Secretagogues in Subjects of a Pediatric GH Deficiency Trial
<b><i>Introduction:</i></b> LUM-201 (ibutamoren, formerly MK-0677) is an orally administered GH secretagogue receptor agonist under development for treatmen...
Atrial Pacing and Thallium 201 Scintigraphy: Combined Use for Diagnosis of Coronary Artery Disease
Atrial Pacing and Thallium 201 Scintigraphy: Combined Use for Diagnosis of Coronary Artery Disease
To evaluate the presence of coronary artery disease (CAD), atrial pacing and thallium 201 scintigraphy were performed in 36 patients with stable angina pectoris who were unable to ...

